PPARG and osteosarcoma: In contrast to these pro-apoptotic actions of PPARγ agonists, the PPARγ agonist troglitazone increased cell proliferation and inhibited staurosporine-induced apoptosis in several osteosarcoma cell lines through Akt activation [171].